157 related articles for article (PubMed ID: 5925076)
1. [Recent results obtained with anti-inflammatory and uricosuric therapeutics in certain peripheral angiopathies. Clinical trials of ketophenylbutazone].
Bourde C
Therapie; 1966; 21(4):1053-61. PubMed ID: 5925076
[No Abstract] [Full Text] [Related]
2. [Antarthritics. 41].
Mayr E
Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
[No Abstract] [Full Text] [Related]
3. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
Mugler A
Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166
[No Abstract] [Full Text] [Related]
4. [Clinical results in therapy of peripheral vascular diseases with ginkgo-biloba].
Bartolo M
Minerva Med; 1973 Nov; 64(79 Suppl):4187-93. PubMed ID: 4592295
[No Abstract] [Full Text] [Related]
5. [Gout and benziodarone].
Thomas J
Rein Foie; 1967; 10():249-60. PubMed ID: 6081452
[No Abstract] [Full Text] [Related]
6. Management of gout and hyperuricemia.
Wisner DE; Simkin PA
Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
[TBL] [Abstract][Full Text] [Related]
7. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
Hamming JJ; van der Drift JH
Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
[No Abstract] [Full Text] [Related]
8. [Vasodilators. Clinical effect in peripheral vascular disorders. A survey of the literature].
Hallén LG
Lakartidningen; 1965 Sep; 62(39):3149-52. PubMed ID: 5330352
[No Abstract] [Full Text] [Related]
9. [Practical problems in gout].
Recordier AM
Mars Med; 1965; 102(5):407-16. PubMed ID: 5889111
[No Abstract] [Full Text] [Related]
10. [Vasodilator drugs in the treatment of peripheral arterial diseases].
Lorentsen E
Tidsskr Nor Laegeforen; 1967 Jun; 87(11):1054-7. PubMed ID: 4860122
[No Abstract] [Full Text] [Related]
11. [The role of thrombocytes in the etiopathogenesis of various vascular disorders].
Hopp L
Orv Hetil; 1981 Dec; 122(50):3065-70. PubMed ID: 7329682
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
Simões Neto E
Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
[No Abstract] [Full Text] [Related]
13. The action of tetranicotinoylfructose in peripheral vascular disease.
Andrews G; Judge TG; Walkey F
Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
[No Abstract] [Full Text] [Related]
14. [The effect of Vasculat on the peripheral blood circulation and the economy of circulatory function].
Herrwerth E; Brenner L
Med Klin; 1966 Dec; 61(49):1969-71. PubMed ID: 5339977
[No Abstract] [Full Text] [Related]
15. [Our experience in the treatment of peripheral vascular diseases with raubasine].
Vercellio G; Costantini S; Giulini S
Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
[No Abstract] [Full Text] [Related]
16. [Treatment of peripheral vascular disorders with dilatol].
Knapik Z; Twardzicki J; Wlodarczykowa J
Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
[No Abstract] [Full Text] [Related]
17. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
Mugler A
Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
[No Abstract] [Full Text] [Related]
18. [Action of MD 1035 in peripheral vascular manifestations].
Barraine R; Efthymiou TP; Marcantoni JP
Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
[No Abstract] [Full Text] [Related]
19. Editorial: Peripheral vasodilators.
Miller RR; Greenblatt DJ
Am J Hosp Pharm; 1975 Dec; 32(12):1231-2. PubMed ID: 1211395
[No Abstract] [Full Text] [Related]
20. [Therapeutic results in disturbed peripheral blood circulation with the vasodilator bencyclane].
Leonard W
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1440+. PubMed ID: 5536666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
